Skip to main content

Table 3 Results of repeated measures ANOVA for the selected myocardial injury markers and inflammatory markers

From: Myocardial injury and inflammatory response in percutaneous device closures of pediatric patent ductus arteriosus

Variable

Source

Sum of squares

df

Mean square

F

P

WBC

Group

252.93

4

63.23

8.320

 < 0.001

Time

10,484.79

4

2621.2

1029.978

 < 0.001

Group * time

249.7

16

15.61

6.132

 < 0.001

CRP

Group

37,028.92

4

9257.23

19.039

 < 0.001

Time

564,635.74

4

141,158.94

824.229

 < 0.001

Group * time

54,752.95

16

3422.06

19.981

 < 0.001

PCT

Group

650.94

4

162.73

32.325

 < 0.001

Time

15,703.78

4

3925.95

1701.594

 < 0.001

Group * time

1005.64

16

62.85

27.242

 < 0.001

IL-6

Group

57,853.78

4

14,463.45

19.326

 < 0.001

Time

3,225,446.55

4

806,361.64

2168.221

 < 0.001

Group * time

177,657.24

16

11,103.58

29.856

 < 0.001

CKMB

Group

9994.76

4

2498.69

95.666

 < 0.001

Time

2743.64

4

685.91

34.398

 < 0.001

Group * time

8340.93

16

521.31

26.143

 < 0.001

cTnl

Group

111.94

4

27.96

649.89

 < 0.001

Time

21.75

4

5.44

151.154

 < 0.001

Group * time

82.29

16

5.14

142.959

 < 0.001

  1. WBC, white blood cell; CRP, C-reactive protein; PCT, procalcitonin; IL6, inflammatory markers including interleukin-6; CKMB, creatine kinase isoenzyme MB; cTnI, troponin I; ANOVA, one-way analysis of variance
  2. Group A: ligation, Group B: clamping; Group C: ligation combined with suturing; Group D: ligation combined with clamping groups; Group E: device group. Repeated measures ANOVA: with effect of Group, effect of Time, or interaction effect between Group and Time all P < 0.001